Skip to main content

Online Only

Original Research, Clinical

Changes in Antipsychotic Medication Use Among Medicare Patients in a Nursing Home, 2010 to 2015

Michele Berrios, CHFP; Bruce Pyenson, FSA, MAAA; Kyle Pérez, MPH; Heidi C. Waters, MBA, PhD

The Hidden Inferno: Burn Pit Exposure in the Military and Its Potential Links to Cancer

Claire Szewczyk

FDA Accelerated the Approval of Columvi for Selected Relapsed or Refractory Large B-Cell Lymphomas

Lynparza FDA Approved, in Combination With Abiraterone and Prednisone (or Prednisolone), for Metastatic Castration-Resistant Prostate Cancer With BRCA Mutation

Epkinly FDA Approved for Relapsed or Refractory Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma

Polivy Received New Indication for First-Line Treatment of Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, and High-Grade B-Cell Lymphoma

AVBCC 2021 Highlights

The Impact of Telehealth on Cancer Care

AVBCC 2021 Highlights

Medically Integrated Oncology Pharmacy Promotes Patient-Centric Care

AVBCC 2021 Highlights

Drug Price Reform with Value in Mind: Can It Happen?

AVBCC 2021 Highlights

Using Value-Based Contracts to Manage Oncology Costs While Keeping Focus on the Patient

1
2

Page 1 of 2
Results 1 - 10 of 16